[
  {
    "date": "2023-12-30",
    "symbol": "CYCN",
    "period": "FY",
    "entityregistrantname": "CYCLERION THERAPEUTICS, INC.",
    "documenttype": "10-K",
    "documentperiodenddate": "2023-12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1755237,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitytaxidentificationnumber": "83-1895370",
    "entityfilenumber": "001-38787",
    "entityincorporationstatecountrycode": "MA",
    "entityaddressaddressline1": "245 First Street, 18th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8778",
    "security12btitle": "Common Stock, no par value",
    "tradingsymbol": "CYCN",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 7571000,
    "prepaidexpensecurrent": 442000,
    "otherassetscurrent": 11000,
    "assetscurrent": 8024000,
    "otherlongterminvestments": 5350000,
    "assets": 13374000,
    "accountspayablecurrent": 1198000,
    "accruedresearchanddevelopmentcurrent": 90000,
    "accruedexpensesandotherliabilitiescurrent": 798000,
    "liabilitiescurrent": 2086000,
    "additionalpaidincapitalcommonstock": 275717000,
    "retainedearningsaccumulateddeficit": -264417000,
    "accumulatedothercomprehensiveincomelossnetoftax": -12000,
    "stockholdersequity": 11288000,
    "liabilitiesandstockholdersequity": 13374000,
    "preferredstocksharesauthorized": 500000,
    "preferredstocksharesissued": 351037,
    "preferredstocksharesoutstanding": 351037,
    "commonstocksharesissued": 2645096,
    "commonstocksharesauthorized": 20000000,
    "commonstocksharesoutstanding": 2474159,
    "revenues": 300000,
    "researchanddevelopmentexpense": 1515000,
    "generalandadministrativeexpense": 8132000,
    "assetimpairmentcharges": 3304000,
    "operatingexpenses": 12951000,
    "operatingincomeloss": -12951000,
    "nonoperatingincomeexpense": 358000,
    "incomelossfromcontinuingoperationsincludingportionattributabletononcontrollinginterest": -12593000,
    "incomelossfromdiscontinuedoperationsnetoftax": 7330000,
    "netincomeloss": -5263000,
    "incomelossfromcontinuingoperationsperbasicshare": -5.39,
    "incomelossfromdiscontinuedoperationsnetoftaxperbasicshare": 3.14,
    "earningspersharebasic": -2.25,
    "incomelossfromcontinuingoperationsperdilutedshare": -5.39,
    "incomelossfromdiscontinuedoperationsnetoftaxperdilutedshare": 3.14,
    "earningspersharediluted": -2.25,
    "weightedaveragenumberofsharesoutstandingbasic": 2338000,
    "weightedaveragenumberofdilutedsharesoutstanding": 2338000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 8000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -5255000,
    "stockissuedduringperiodvaluenewissues": 1953000,
    "stockissuedduringperiodsharesnewissues": 225000,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 3047000,
    "issuanceofpreferredstock": 351037,
    "stockissuedduringperiodvalueexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 24000,
    "stockissuedduringperiodsharesexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 44227,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 29063,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1042000,
    "sharebasedcompensationexpenserelatedtoissuanceofstockoptionstononemployees": 25000,
    "fractionalsharesissuance": -67,
    "profitloss": -5263000,
    "discontinuedoperationgainlossfromdisposalofdiscontinuedoperationbeforeincometax": 15752000,
    "sharebasedcompensation": 1067000,
    "increasedecreaseinaccountsreceivable": -96000,
    "increasedecreaseinprepaidexpense": -363000,
    "increasedecreaseinothercurrentassets": -160000,
    "increasedecreaseinoperatingleaseassets": -108000,
    "increasedecreaseinothernoncurrentassets": -213000,
    "increasedecreaseinaccountspayabletrade": -1772000,
    "increasedecreaseinaccruedresearchanddevelopment": -2185000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -1584000,
    "netcashprovidedbyusedinoperatingactivities": -21245000,
    "proceedsfromdivestitureofbusinesses": 10402000,
    "netcashprovidedbyusedininvestingactivities": 10402000,
    "proceedsfromissuanceofcommonstock": 5000000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 24000,
    "netcashprovidedbyusedinfinancingactivities": 5024000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -5811000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7571000,
    "noncashgainondisposalofdiscontinuedoperations": 5350000,
    "commercializationmilestonepayments": 585000000,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "leasepracticalexpedientspackage": "true",
    "operatingleaseimpairmentloss": 3300000,
    "professionalfees": 1100000,
    "interestandotherincome": 400000,
    "cashandcashequivalentsfairvaluedisclosure": 7244000,
    "closingcostsaleoftransferredassets": 1300000,
    "transactioncostssaleoftransferredassets": 900000,
    "disposalgroupincludingdiscontinuedoperationrevenue": 50000,
    "disposalgroupincludingdiscontinuedoperationresearchanddevelopmentexpense": 4439000,
    "disposalgroupincludingdiscontinuedoperationgeneralandadministrativeexpense": 4033000,
    "disposalgroupincludingdiscontinueoperationoperatingexpenses": 8472000,
    "disposalgroupincludingdiscontinuedoperationoperatingincomeloss": -8422000,
    "gainlossondisposalofdiscontinuedoperations": 15752000,
    "discontinuedoperationincomelossfromdiscontinuedoperationduringphaseoutperiodnetoftax": 7330000,
    "disposalgroupincludingdiscontinuedoperationsharebasedcompensationexpense": 505000,
    "settlementofassetretirementobligationsthroughnoncashpaymentsamount": 8000000,
    "settlementofassetretirementobligationsthroughnoncashpaymentsamountreimbursement": 2402000,
    "transfertoinvestments": 5350000,
    "propertyplantandequipmentgross": 126000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 126000,
    "accruedsalariescurrent": 11000,
    "accruedprofessionalfeescurrent": 685000,
    "othersundryliabilitiescurrent": 102000,
    "severancecosts1": 100000,
    "operatingleaseexpense": 200000,
    "lesseeoperatingleasetermofcontract": "P8Y10M17D",
    "leasecost": 100000,
    "prepaidroomsbalancerelatedtootherassets": 1400000,
    "allocatedsharebasedcompensationexpense": 421000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingmeasurementthresholdnumberofconsecutivetradingdaysconsidered": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 291368,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 189.09,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.95,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 37675,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedupongrant": 28750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 77848,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 246819,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y1M6D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 157.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 214.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0347,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9319,
    "weightedaverageremainingcontractualtermcancelledorforfeited": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 170937,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 3097,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 15.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 17.5,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 351037,
    "amountofdilutivesecuritiesstockoptionsandrestrictivestockunits": 298868000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 405000,
    "operatinglosscarryforwards": 177000000,
    "taxcreditcarryforwardamount": 10800000,
    "otherinformationpertainingtoincometaxes": "begin to expire in 2040 and will continue to expire through 2042",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -5181000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -82000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -5263000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1105000,
    "incometaxreconciliationstateandlocalincometaxes": -5000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": -9000,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedpaymentarrangementshortfallswindfallsamount": 1196000,
    "incometaxreconciliationnondeductibleexpense": 1000,
    "incometaxreconciliationtaxcredits": 500000,
    "incometaxreconciliationotheradjustments": 17000,
    "deferredtaxassetsoperatinglosscarryforwards": 48535000,
    "deferredtaxassetstaxcreditcarryforwards": 10388000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7071000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 16440000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 2000,
    "deferredtaxassetsgross": 82436000,
    "netdeferredassetsliabilitiesbeforevaluationallowance": 82436000,
    "deferredtaxassetsvaluationallowance": 82436000,
    "definedcontributionplantypeextensiblelist": "http://fasb.org/us-gaap/2023#QualifiedPlanMember",
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.01,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "definedcontributionplanemployermatchingcontributionmaximum": 6000,
    "definedcontributionplancostrecognized": 100000,
    "restructuringcosts": 600000,
    "restructuringcharges": -565000,
    "paymentsforrestructuring": 1374000,
    "allowableexpensesongrantrevenue": 100000
  },
  {
    "date": "2022-12-30",
    "symbol": "CYCN",
    "period": "FY",
    "entityregistrantname": "CYCLERION THERAPEUTICS, INC.",
    "documenttype": "10-K",
    "documentperiodenddate": "2022-12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1755237,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitytaxidentificationnumber": "83-1895370",
    "entityfilenumber": "001-38787",
    "entityincorporationstatecountrycode": "MA",
    "entityaddressaddressline1": "245 First Street, 18th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8778",
    "security12btitle": "Common Stock, no par value",
    "tradingsymbol": "CYCN",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 13382000,
    "accountsreceivablenetcurrent": 96000,
    "prepaidexpensecurrent": 805000,
    "otherassetscurrent": 537000,
    "assetscurrent": 14820000,
    "operatingleaserightofuseasset": 1218000,
    "otherassetsnoncurrent": 2041000,
    "assets": 18079000,
    "accountspayablecurrent": 2970000,
    "accruedresearchanddevelopmentcurrent": 2275000,
    "accruedexpensesandotherliabilitiescurrent": 2382000,
    "liabilitiescurrent": 7627000,
    "retainedearningsaccumulateddeficit": -259154000,
    "additionalpaidincapitalcommonstock": 269626000,
    "accumulatedothercomprehensiveincomelossnetoftax": -20000,
    "stockholdersequity": 10452000,
    "liabilitiesandstockholdersequity": 18079000,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 43518724,
    "commonstocksharesoutstanding": 43518724,
    "revenuefromdevelopmentagreement": 297000,
    "revenuefromgrant": 1328000,
    "revenues": 1625000,
    "researchanddevelopmentexpense": 31493000,
    "generalandadministrativeexpense": 14504000,
    "operatingexpenses": 45997000,
    "operatingincomeloss": -44372000,
    "nonoperatingincomeexpense": 294000,
    "netincomeloss": -44078000,
    "earningspersharebasic": -1.01,
    "earningspersharediluted": -1.01,
    "weightedaveragenumberofsharesoutstandingbasic": 43469000,
    "weightedaveragenumberofdilutedsharesoutstanding": 43469000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 3000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -44075000,
    "stockissuedduringperiodvalueexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 29000,
    "stockissuedduringperiodsharesexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 108539,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5091000,
    "sharebasedcompensationexpenserelatedtoissuanceofstockoptionstononemployees": 1161000,
    "profitloss": -44078000,
    "depreciationandamortization": 65000,
    "sharebasedcompensation": 6252000,
    "increasedecreaseinaccountsreceivable": -4000,
    "increasedecreaseinprepaidexpense": -123000,
    "increasedecreaseinothercurrentassets": 69000,
    "increasedecreaseinoperatingleaseassets": -184000,
    "increasedecreaseinothernoncurrentassets": -366000,
    "increasedecreaseinaccountspayabletrade": 1142000,
    "increasedecreaseinaccruedresearchanddevelopment": -4078000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -522000,
    "netcashprovidedbyusedinoperatingactivities": -40611000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 29000,
    "netcashprovidedbyusedinfinancingactivities": 29000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -40579000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 13382000,
    "healthcaretrustamountdescription": "recently capped enrollment in our signal-seeking clinical study of zagociguat for the potential treatment of Alzheimer's disease with vascular pathology (\"ADv\")..Data from the ADv study are expected in the first half of 2023. The ADv study is supported in part by a $2 million grant from the Alzheimer’s Association’s Part the Cloud-Gates Partnership Grant Program (the \"PTC Grant\").",
    "precommercialmilestonesandtotalpotentialfuturedevelopment": 225000000,
    "commercializationmilestonepayments": 585000000,
    "numberofcommonstocksold": 3353059,
    "proceedsfromissuanceofcommonstock": 12500000,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "subleaseterminationagreementestimatedfairvalueofrooms": 1500000,
    "subleaseterminationagreementestimatedfairvalueofservices": 2900000,
    "prepaidroomsbalancerelatedtootherassets": 1400000,
    "lesseeoperatingleasetermofcontract": "P8Y10M17D",
    "shorttermborrowings": 3500000,
    "initialtermofagreement": "P2Y",
    "developmentagreementrenewalperiod": "P1Y",
    "developmentagreementperiodfornotificationofcancellation": "P6M",
    "professionalfees": 1700000,
    "interestandotherincome": 300000,
    "cashandcashequivalentsfairvaluedisclosure": 12357000,
    "propertyplantandequipmentgross": 2174000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2181000,
    "accruedbonusescurrent": 238000,
    "accruedsalariescurrent": 246000,
    "accruedvacationcurrent": 186000,
    "accruedprofessionalfeescurrent": 835000,
    "accruedemployeebenefitscurrent": 809000,
    "othersundryliabilitiescurrent": 68000,
    "operatingleaseexpense": 200000,
    "leasecost": 300000,
    "allocatedsharebasedcompensationexpense": 2915000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingmeasurementthresholdnumberofconsecutivetradingdaysconsidered": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P4Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1695303,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7311893,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1463836,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5282088,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.989,
    "weightedaverageremainingcontractualtermcancelledorforfeited": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 815587,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 53999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 23218,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 14.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 13.43,
    "amountofdilutivesecuritiesstockoptionsandrestrictivestockunits": 7611893000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 12485000,
    "operatinglosscarryforwards": 172000000,
    "taxcreditcarryforwardamount": 10200000,
    "otherinformationpertainingtoincometaxes": "begin to expire in 2040 and will continue to expire through 2042",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -44063000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -15000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -44078000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -9256000,
    "incometaxreconciliationstateandlocalincometaxes": -2693000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 266000,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedpaymentarrangementshortfallswindfallsamount": 833000,
    "incometaxreconciliationnondeductibleexpense": 14000,
    "incometaxreconciliationtaxcredits": 1652000,
    "incometaxreconciliationotheradjustments": 3000,
    "deferredtaxassetsoperatinglosscarryforwards": 47079000,
    "deferredtaxassetstaxcreditcarryforwards": 9848000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8354000,
    "deferredtaxassetsliabilitiespropertyplantandequipment": 1000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 17399000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 340000,
    "deferredtaxassetsgross": 83021000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 333000,
    "deferredtaxliabilityprepaidsubleasetermination": 658000,
    "deferredincometaxliabilities": 991000,
    "netdeferredassetsliabilitiesbeforevaluationallowance": 82030000,
    "deferredtaxassetsvaluationallowance": 82030000,
    "definedcontributionplantypeextensiblelist": "http://fasb.org/us-gaap/2022#QualifiedPlanMember",
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.01,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "definedcontributionplanemployermatchingcontributionmaximum": 6000,
    "definedcontributionplancostrecognized": 200000,
    "restructuringreservecurrent": 809000,
    "restructuringcharges": -1327000,
    "paymentsforrestructuring": 518000,
    "allowableexpensesongrantrevenue": 1300000
  },
  {
    "date": "2021-12-30",
    "symbol": "CYCN",
    "period": "FY",
    "entityregistrantname": "CYCLERION THERAPEUTICS, INC.",
    "documenttype": "10-K",
    "documentperiodenddate": "2021-12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1755237,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitytaxidentificationnumber": "83-1895370",
    "entityfilenumber": "001-38787",
    "entityincorporationstatecountrycode": "MA",
    "entityaddressaddressline1": "245 First Street",
    "entityaddressaddressline2": "18th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8778",
    "security12btitle": "Common Stock, no par value",
    "tradingsymbol": "CYCN",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 53961000,
    "accountsreceivablenetcurrent": 100000,
    "prepaidexpensecurrent": 928000,
    "otherassetscurrent": 468000,
    "assetscurrent": 55457000,
    "propertyplantandequipmentnet": 65000,
    "operatingleaserightofuseasset": 1402000,
    "otherassetsnoncurrent": 2407000,
    "assets": 59331000,
    "accountspayablecurrent": 1828000,
    "accruedresearchanddevelopmentcurrent": 6353000,
    "accruedexpensesandotherliabilitiescurrent": 2904000,
    "liabilitiescurrent": 11085000,
    "retainedearningsaccumulateddeficit": -215076000,
    "additionalpaidincapitalcommonstock": 263345000,
    "accumulatedothercomprehensiveincomelossnetoftax": -23000,
    "stockholdersequity": 48246000,
    "liabilitiesandstockholdersequity": 59331000,
    "commonstocksharesoutstanding": 43410185,
    "revenuefromlicense": 3000000,
    "revenuefromdevelopmentagreement": 320000,
    "revenuefromgrant": 622000,
    "revenues": 3942000,
    "researchanddevelopmentexpense": 37636000,
    "generalandadministrativeexpense": 20620000,
    "gainlossonmodificationoflease": 881000,
    "operatingexpenses": 59137000,
    "operatingincomeloss": -55195000,
    "gainslossesonextinguishmentofdebt": 3564000,
    "nonoperatingincomeexpense": -16000,
    "netincomeloss": -51647000,
    "earningspersharebasicanddiluted": -1.32,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 39144000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 4000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -51643000,
    "stockissuedduringperiodvaluenewissues": 18028000,
    "stockissuedduringperiodsharesnewissues": 5735988,
    "stockissuedduringperiodvalueexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 282000,
    "stockissuedduringperiodsharesexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 273838,
    "stockissuedduringperiodsharessharebasedcompensation": 3353059,
    "stockissuedduringperiodvaluesinsharebasedcompensation": 12475000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7915000,
    "sharebasedcompensationexpenserelatedtoissuanceofstockoptionstononemployees": 1696000,
    "profitloss": -51647000,
    "depreciationandamortization": 472000,
    "gainlossonsaleofpropertyplantequipment": 6322000,
    "gainlossonleasemodificationandtermination": 881000,
    "sharebasedcompensation": 9611000,
    "increasedecreaseinaccountsreceivable": -100000,
    "increasedecreaseinaccountsreceivablerelatedparties": 127000,
    "increasedecreaseinprepaidexpense": -112000,
    "increasedecreaseinothercurrentassets": 1244000,
    "increasedecreaseinoperatingleaseassets": -59000,
    "increasedecreaseinothernoncurrentassets": 366000,
    "increasedecreaseinaccountspayabletrade": 679000,
    "increasedecreaseinaccountspayablerelatedparties": -286000,
    "increasedecreaseinaccruedresearchanddevelopment": 4932000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -4335000,
    "increasedecreaseinoperatingleaseliabilities": -1048000,
    "netcashprovidedbyusedinoperatingactivities": -36517000,
    "paymentstoacquirepropertyplantandequipment": 7000,
    "proceedsfromsaleofpropertyplantandequipment": 1464000,
    "netcashprovidedbyusedininvestingactivities": 1457000,
    "proceedsfromissuanceofprivateplacement": 30503000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 282000,
    "netcashprovidedbyusedinfinancingactivities": 30785000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 4000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -4271000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 53961000,
    "healthcaretrustamountdescription": "We have initiated exploratory clinical trials with CY6463 ADv, CIAS, and MELAS. The ADv study will be supported in part by a grant from the Alzheimer’s Association’s Part the Cloud-Gates Partnership Grant Program, which provides Cyclerion with $2 million of funding over two years.",
    "proceedsfromissuanceofprivateplacementnetofissuancecosts": 219800,
    "proceedsfromissuanceofcommonstock": 12500000,
    "commissionpaidfromgrossproceedsofsalesofcommonstock": 400000,
    "cashequivalentsatcarryingvalue": 54000000,
    "numberofcommonstocksold": 3353059,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "writeoffleaseunamortizeddirectcost": 200000,
    "gainlossonterminationoflease": 900000,
    "shorttermborrowings": 3500000,
    "interestexpense": 100000,
    "initialtermofagreement": "P2Y",
    "developmentagreementrenewalperiod": "P1Y",
    "developmentagreementperiodfornotificationofcancellation": "P6M",
    "cashandcashequivalentsfairvaluedisclosure": 52917000,
    "propertyplantandequipmentgross": 2214000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2200000,
    "accruedbonusescurrent": 1369000,
    "accruedsalariescurrent": 266000,
    "accruedvacationcurrent": 345000,
    "accruedprofessionalfeescurrent": 398000,
    "accruedemployeebenefitscurrent": 28000,
    "othersundryliabilitiescurrent": 498000,
    "leasemodificationdecreaseinsecuritydeposit": 1200000,
    "leasecost": 2400000,
    "variableleasecost": 700000,
    "decreaseinrightofuseassetsrelatedtoleasemodificationsandtermination": 42058000,
    "decreaseinoperatingleaseliabilitiesrelatedtoleasemodificationsandtermination": 41177000,
    "operatingleasepayments": 1887000,
    "subleaseterminationagreementestimatedfairvalueofrooms": 1500000,
    "subleaseterminationagreementestimatedfairvalueofservices": 2900000,
    "deferredrentreceivablesnet": 1300000,
    "operatingleaseexpense": 100000,
    "allocatedsharebasedcompensationexpense": 3945000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingmeasurementthresholdnumberofconsecutivetradingdaysconsidered": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P4Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y3M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.17,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 8100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1176250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7080426,
    "stockissuedduringperiodsharesstockoptionsexercised": 72419,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1449761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4518213,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0109,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8545,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 92804,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 39369,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 143774,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 97704,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 13.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 12.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.41,
    "amountofdilutivesecuritiesstockoptionsandrestrictivestockunits": 7530426000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 16424000,
    "operatinglosscarryforwards": 160000000,
    "taxcreditcarryforwardamount": 8400,
    "otherinformationpertainingtoincometaxes": "begin to expire in 2039 and will continue to expire through 2040",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -51686000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 39000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -51647000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -10846000,
    "incometaxreconciliationstateandlocalincometaxes": -3631000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": -911000,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedpaymentarrangementshortfallswindfallsamount": 946000,
    "incometaxreconciliationnondeductibleexpense": -420000,
    "debtinstrumentdecreaseforgiveness": 748000,
    "incometaxreconciliationtaxcredits": 805000,
    "incometaxreconciliationotheradjustments": -9000,
    "deferredtaxassetsoperatinglosscarryforwards": 43700000,
    "deferredtaxassetstaxcreditcarryforwards": 8044000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7702000,
    "deferredtaxassetspropertyplantandequipment": 1000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 11147000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 91000,
    "deferredtaxassetstaxdeferredexpenseother": 4000,
    "deferredtaxassetsgross": 70687000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": -383000,
    "deferredtaxliabilityprepaidsubleasetermination": -758000,
    "deferredincometaxliabilities": 1141000,
    "netdeferredassetsliabilitiesbeforevaluationallowance": 69546000,
    "deferredtaxassetsvaluationallowance": 69546000,
    "definedcontributionplantypeextensiblelist": "http://fasb.org/us-gaap/2021-01-31#QualifiedPlanMember",
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.01,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "definedcontributionplanemployermatchingcontributionmaximum": 6000,
    "definedcontributionplancostrecognized": 300000,
    "restructuringreservecurrent": 28000,
    "restructuringcharges": -878000,
    "paymentsforrestructuring": 4490000,
    "allowableexpensesongrantrevenue": 600000
  },
  {
    "date": "2020-12-30",
    "symbol": "CYCN",
    "period": "FY",
    "entityregistrantname": "CYCLERION THERAPEUTICS, INC.",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1755237,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitytaxidentificationnumber": "83-1895370",
    "entityfilenumber": "001-38787",
    "entityincorporationstatecountrycode": "MA",
    "entityaddressaddressline1": "245 First Street",
    "entityaddressaddressline2": "18th Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8778",
    "security12btitle": "Common Stock, no par value",
    "tradingsymbol": "CYCN",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 54395000,
    "accountsreceivablerelatedpartiescurrent": 127000,
    "prepaidexpensecurrent": 816000,
    "otherassetscurrent": 3163000,
    "assetscurrent": 58501000,
    "restrictedcashandcashequivalentsnoncurrent": 3837000,
    "propertyplantandequipmentnet": 6865000,
    "operatingleaserightofuseasset": 43400000,
    "otherassetsnoncurrent": 2773000,
    "assets": 115378000,
    "accountspayablecurrent": 1149000,
    "accountspayablerelatedpartiescurrent": 286000,
    "accruedresearchanddevelopmentcurrent": 1421000,
    "accruedexpensesandotherliabilitiescurrent": 7294000,
    "notespayablecurrent": 3509000,
    "operatingleaseliabilitycurrent": 3300000,
    "liabilitiescurrent": 16952000,
    "operatingleaseliabilitynoncurrent": 38900000,
    "retainedearningsaccumulateddeficit": -163429000,
    "additionalpaidincapitalcommonstock": 222949000,
    "accumulatedothercomprehensiveincomelossnetoftax": -27000,
    "stockholdersequity": -27000,
    "liabilitiesandstockholdersequity": 115378000,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 34047300,
    "commonstocksharesoutstanding": 34047300,
    "revenuefromcontractwithcustomerexcludingassessedtax": 2300000,
    "researchanddevelopmentexpense": 56414000,
    "generalandadministrativeexpense": 700000,
    "gainlossonmodificationoflease": -400000,
    "operatingexpenses": 83561000,
    "operatingincomeloss": -81265000,
    "subleaseterminationincomelossnet": 2875000,
    "investmentincomenonoperating": 588000,
    "netincomeloss": -77802000,
    "earningspersharebasicanddiluted": -2.56,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 30403000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -7000,
    "othercomprehensiveincomelossnetoftax": -7000,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -77809000,
    "stockissuedduringperiodsharesnewissues": 24250,
    "stockissuedduringperiodvalueexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 331000,
    "stockissuedduringperiodsharesexerciseofstockoptionsrestrictedstockunitsandemployeestockpurchaseplans": 386667,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14992000,
    "profitloss": -77802000,
    "depreciationandamortization": 2297000,
    "gainlossonsaleofpropertyplantequipment": 800000,
    "sharebasedcompensation": 14992000,
    "increasedecreaseinaccountsreceivablerelatedparties": -1346000,
    "increasedecreaseinprepaidexpense": -1150000,
    "increasedecreaseinothercurrentassets": 55000,
    "increasedecreaseinoperatingleaseassets": 2598000,
    "increasedecreaseinothernoncurrentassets": 888000,
    "increasedecreaseinaccountspayabletrade": -1301000,
    "increasedecreaseinaccountspayablerelatedparties": 205000,
    "increasedecreaseinaccruedresearchanddevelopment": -776000,
    "increasedecreaseinoperatingleaseliabilities": -2692000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -1983000,
    "netcashprovidedbyusedinoperatingactivities": -72490000,
    "paymentstoacquirepropertyplantandequipment": 1524000,
    "proceedsfromsaleofpropertyplantandequipment": 1542000,
    "netcashprovidedbyusedininvestingactivities": 18000,
    "proceedsfromissuanceofprivateplacement": 24250000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 331000,
    "proceedsfromnotespayable": 3509000,
    "netcashprovidedbyusedinfinancingactivities": 28090000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -7000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -44389000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 58232000,
    "paymentsforleasemodificationterminationfeeandotherinitialdirectcosts": 6507000,
    "restrictedcashandcashequivalents": 3837000,
    "numberofreportablesegments": 1,
    "securitydepositliability": 3800000,
    "restrictedcashandcashequivalentsnoncurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:NoncurrentAssets",
    "propertyplantandequipmentusefullife": "P3Y",
    "leasepracticalexpedientspackage": "true",
    "shorttermborrowings": 3500000,
    "initialtermofagreement": "P2Y",
    "developmentagreementrenewalperiod": "P1Y",
    "developmentagreementperiodfornotificationofcancellation": "P6M",
    "professionalfees": 1700000,
    "interestandotherincome": 300000,
    "subleaseincome": 300000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 200000,
    "duetorelatedpartiescurrentandnoncurrent": 300000,
    "duefromrelatedparties": 100000,
    "relatedpartytransactionresearchanddevelopmenttransactionsupportservices": 1500000,
    "cashandcashequivalentsfairvaluedisclosure": 53240000,
    "propertyplantandequipmentgross": 17152000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 10287000,
    "propertyplantandequipmentdisposals": 1000000,
    "accruedbonusescurrent": 1720000,
    "accruedsalariescurrent": 514000,
    "accruedvacationcurrent": 555000,
    "accruedprofessionalfeescurrent": 689000,
    "accruedemployeebenefitscurrent": 3640000,
    "othersundryliabilitiescurrent": 176000,
    "operatingleaseliability": 42226000,
    "leasemodificationdecreaseinsecuritydeposit": 1200000,
    "decreaseinrightofuseassetsrelatedtoleasemodification": 27333000,
    "decreaseinoperatingleaseliabilitiesrelatedtoleasemodification": 29002000,
    "leasecost": 8600000,
    "variableleasecost": 2200000,
    "operatingleasepayments": 7411000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y6M0D",
    "operatingleaseweightedaveragediscountratepercent": 0.061,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5742000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5908000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6080000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6256000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6438000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 24047000,
    "lesseeoperatingleaseliabilitypaymentsdue": 54471000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 12245000,
    "grosssubleaseincomenetofrentexpense": 1500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationnumberofemployeesaffected": 143,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 7500000,
    "allocatedsharebasedcompensationexpense": 14992000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingmeasurementthresholdnumberofconsecutivetradingdaysconsidered": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P4Y7M6D",
    "sharebasedcompensationexpense": 100000,
    "deferredcompensationarrangementwithindividualallocatedsharebasedcompensationexpense": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y10M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1382846,
    "stockissuedduringperiodsharesstockoptionsexercised": 17571,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 75000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4020960,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.65,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 630000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 191000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9173,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 294913,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 221181,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 210381,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 14.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 15.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.92,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 2400000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 294913,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 23473000,
    "operatinglosscarryforwards": 98900000,
    "taxcreditcarryforwardamount": 7500000,
    "otherinformationpertainingtoincometaxes": "Federal credits begin to expire in 2039 and will continue to expire through 2040.  State credits begin to expire in 2022 and continue through 2034",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -77884000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 82000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -77802000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -16338000,
    "incometaxreconciliationstateandlocalincometaxes": -5619000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 16000,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedpaymentarrangementshortfallswindfallsamount": 1047000,
    "incometaxreconciliationnondeductibleexpense": -94000,
    "incometaxreconciliationtaxcredits": 2469000,
    "incometaxreconciliationotheradjustments": -16000,
    "deferredtaxassetsoperatinglosscarryforwards": 27007000,
    "deferredtaxassetstaxcreditcarryforwards": 7185000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5890000,
    "deferredtaxassetsoperatingleaseliabilities": 11536000,
    "deferredtaxassetspropertyplantandequipment": 1362000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 12684000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 518000,
    "deferredtaxassetsgross": 66182000,
    "deferredtaxliabilitiesoperatingleaserightofuseassets": 11857000,
    "deferredtaxliabilityprepaidsubleasetermination": 1203000,
    "deferredincometaxliabilities": 13060000,
    "netdeferredassetsliabilitiesbeforevaluationallowance": 53122000,
    "deferredtaxassetsvaluationallowance": 53122000,
    "definedcontributionplantypeextensiblelist": "us-gaap:DefinedContributionPlanTypeExtensibleList",
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.75,
    "definedcontributionplanemployermatchingcontributionmaximum": 6000,
    "definedcontributionplancostrecognized": 500000,
    "severancecosts1": 200000,
    "restructuringreservecurrent": 3640000,
    "restructuringcharges": 158000,
    "paymentsforrestructuring": 2137000,
    "restructuringreserveaccrualadjustment1": -30000
  }
]